Connect with us

Headlines

EssilorLuxottica Discovers $213M Fraud at Thailand Plant

The company is trying to recover the money.

mm

Published

on

EssilorLuxottica announced that it has discovered fraudulent financial activities at one of its plants in Thailand.

The fraud, which occurred within subsidiary Essilor International, amounts to $213 million “before insurance, pending legal actions and anticipated recovery of further funds currently frozen on various bank accounts,” the company said in a statement.

The company said it has filed complaints in Thailand and in other jurisdictions.

“The employees known to date to be associated with these fraudulent activities have been terminated,” the company stated. “Additional internal controls have been put in place at Essilor International worldwide in order to strengthen existing security processes.”

Advertisement

EssilorLuxottica said it has “mobilized all available internal and external resources to put an immediate end to these fraudulent activities and implement remedial actions.”

Bloomberg reports that a spokeswoman “declined to identify the plant or say how many people were involved in the case.”

Read more at Bloomberg

SPONSORED VIDEO

Meet the Next Generation of Smart Glasses

Ray-Ban Meta is now available with a full range of lenses, as a complete pair or edged lens. Prescription orders eligible through select insurance providers, including Eyemed and private pay. The Ray-Ban Meta collection combines iconic design with cutting-edge technology. Capture life’s best moments and livestream to Facebook and Instagram with an upgraded 12 MP camera and five-mic system. Stay connected with hands-free calls and messages. Listen to your favorite tracks through built-in speakers. Spark your creativity, get information and control your glasses with your voice – powered by Meta AI. All while keeping your phone in your pocket. For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular